Details for Patent: 9,724,471
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 9,724,471 protect, and when does it expire?
Patent 9,724,471 protects AUVI-Q, EVZIO, and EVZIO (AUTOINJECTOR), and is included in three NDAs.
This patent has one hundred and eight patent family members in fourteen countries.
Summary for Patent: 9,724,471
| Title: | Devices, systems, and methods for medicament delivery |
| Abstract: | Certain exemplary embodiments comprise can comprise an auto-injector, which can comprise: a vial configured to store and/or contain an injectable medicament, the vial defining a vial longitudinal axis, and a housing comprising the vial. In various embodiments, the injectable medicament can be a medicine, medication, drug, pharmaceutical, prescriptive, agent, antidote, anti-venom, hormone, stimulant, vasodilator, anesthetic, and/or nutritional supplement that is substantially ready for injection. |
| Inventor(s): | Edwards; Evan T. (Charlottesville, VA), Edwards; Eric S. (Moseley, VA), Licata; Mark J. (Doswell, VA) |
| Assignee: | kaleo, Inc. (Richmond, VA) |
| Application Number: | 14/244,311 |
|
Patent Claim Types: see list of patent claims | Use; Device; Dosage form; |
Drugs Protected by US Patent 9,724,471
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-003 | Nov 17, 2017 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | METHOD FOR CONFIRMING DOSE DELIVERY | See Plans and Pricing | |||
| Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-002 | Aug 10, 2012 | BX | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | METHOD FOR CONFIRMING DOSE DELIVERY | See Plans and Pricing | ||
| Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-001 | Aug 10, 2012 | BX | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | METHOD FOR CONFIRMING DOSE DELIVERY | See Plans and Pricing | ||
| Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 205787-001 | Apr 3, 2014 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | METHOD FOR CONFIRMING DOSE DELIVERY | See Plans and Pricing | |||
| Kaleo Inc | EVZIO (AUTOINJECTOR) | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 209862-001 | Oct 19, 2016 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | METHOD FOR CONFIRMING DOSE DELIVERY | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,724,471
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2004325202 | See Plans and Pricing | |||
| Australia | 2006210865 | See Plans and Pricing | |||
| Australia | 2007245139 | See Plans and Pricing | |||
| Australia | 2009200841 | See Plans and Pricing | |||
| Australia | 2009246525 | See Plans and Pricing | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
